Thrombolytic therapy for ischemic stroke - Suitable for children? Commentary

Nature Clinical Practice Neurology

Volumn 3, Issue 9, 2007, Pages 494-495

  Fullerton, Heather J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACCURACY; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHILD; CHILD CARE; CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DRUG INDICATION; FIBRINOLYTIC THERAPY; HEART INFARCTION; HOSPITALIZATION COST; HUMAN; OUTCOME ASSESSMENT; PATIENT CODING; PATIENT SAFETY; PNEUMONIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 34548493455     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0581     Document Type: Short Survey

References (3)

1. [No authors listed] (1995) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333: 1581-1587
2. Golomb MR et al. (2006) Accuracy and yield of ICD-9 codes for identifying children with ischemic stroke. Neurology 67: 2053-2055
3. Johnston SC et al. (2001) Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 32: 1061-1068